semaglutide results 1 month ✨ NEW LOOK. SAME TRUSTED RESULTS. ✨ Our GLP-1 Weight Loss Program has been part of our care for some time—but we're excited to re-introduce it with a fresh, elevated design GLP-1 Weight Loss Results |

ASC37 is the only asset in the pipeline with a credible oral-tablet development plan that is not dependent on an engineered delivery device (as Rani's is)

GLP-1 Agonists Market Growth Forecast 2033 - - The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period

ISSN 1755-148X

Side effects at 0.25mg are typically mild and temporary, mainly nausea (in 2540% of users) and constipation, both resolving within 12 weeks as your body adapts

Good quality wraparound care for patients taking GLP-1 agonists must go further than simple dietary advice as recommended by the National Institute for Health and Care Excellence, she advised